| Attribute |
Value |
| 52 Week Change |
-0.044745505 |
| Address1 |
Else-Kröner-Strasse 1 |
| All Time High |
57.94 |
| All Time Low |
3.35 |
| Ask |
23.06 |
| Ask Size |
400 |
| Average Analyst Rating |
3.1 - Hold |
| Average Daily Volume10 Day |
637,850 |
| Average Daily Volume3 Month |
700,954 |
| Average Volume |
700,954 |
| Average Volume10Days |
637,850 |
| Beta |
0.839 |
| Bid |
23.05 |
| Bid Size |
300 |
| Book Value |
27.543177 |
| City |
Bad Homburg |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Germany |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
23.1 |
| Current Ratio |
1.071 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,786,665,600 |
| Day High |
23.24 |
| Day Low |
22.91 |
| Debt To Equity |
81.131 |
| Dividend Date |
1,780,876,800 |
| Dividend Rate |
0.87 |
| Dividend Yield |
3.75 |
| Earnings Call Timestamp End |
1,785,830,400 |
| Earnings Call Timestamp Start |
1,785,830,400 |
| Earnings Growth |
0.055 |
| Earnings Quarterly Growth |
-0.031 |
| Earnings Timestamp |
1,785,783,600 |
| Earnings Timestamp End |
1,793,736,000 |
| Earnings Timestamp Start |
1,793,736,000 |
| Ebitda |
2,721,596,928 |
| Ebitda Margins |
0.14009 |
| Enterprise To Ebitda |
8.519 |
| Enterprise To Revenue |
1.193 |
| Enterprise Value |
23,185,582,080 |
| Eps Current Year |
2.06725 |
| Eps Forward |
3.6631906 |
| Eps Trailing Twelve Months |
1.92 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,779,408,000 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
23.9416 |
| Fifty Day Average Change |
-0.8416004 |
| Fifty Day Average Change Percent |
-0.03515222 |
| Fifty Two Week Change Percent |
-4.4745502 |
| Fifty Two Week High |
27.64 |
| Fifty Two Week High Change |
-4.539999 |
| Fifty Two Week High Change Percent |
-0.16425467 |
| Fifty Two Week Low |
20.02 |
| Fifty Two Week Low Change |
3.08 |
| Fifty Two Week Low Change Percent |
0.15384614 |
| Fifty Two Week Range |
20.02 - 27.64 |
| Financial Currency |
EUR |
| First Trade Date Milliseconds |
842,967,000,000 |
| Five Year Avg Dividend Yield |
1.3 |
| Float Shares |
397,115,483 |
| Forward Eps |
3.6631906 |
| Forward P E |
6.3059783 |
| Free Cashflow |
2,022,340,224 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
107,226 |
| Fullday Change |
-0.17 |
| Fullday Change Percent |
-0.730555 |
| Fullday Price |
23.1 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.26354998 |
| Gross Profits |
5,120,064,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0 |
| Held Percent Institutions |
0.099180005 |
| Implied Shares Outstanding |
532,219,370 |
| Industry |
Medical Care Facilities |
| Industry Disp |
Medical Care Facilities |
| Industry Key |
medical-care-facilities |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,779,408,000 |
| Last Dividend Value |
0.872 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,354,579,200 |
| Last Split Factor |
2:1 |
| Long Business Summary |
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany. |
| Long Name |
Fresenius Medical Care AG |
| Market |
us_market |
| Market Cap |
12,294,267,904 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_384522 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-08-29 |
| Net Income To Common |
937,780,992 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
12,384,744,739 |
| Number Of Analyst Opinions |
7 |
| Open |
23.16 |
| Operating Cashflow |
2,830,430,976 |
| Operating Margins |
0.10773 |
| Payout Ratio |
0.45029998 |
| Peg Ratio |
0.81 |
| Phone |
49 6172 609 0 |
| Post Market Change |
0.0 |
| Post Market Change Percent |
0.0 |
| Post Market Price |
23.1 |
| Post Market Time |
1,787,959,804 |
| Prev Name |
Fresenius Medical Care AG & Co. KGaA |
| Previous Close |
23.27 |
| Price Eps Current Year |
11.174266 |
| Price Hint |
2 |
| Price To Book |
0.83868325 |
| Price To Sales Trailing12 Months |
0.63283956 |
| Profit Margins |
0.048270002 |
| Quick Ratio |
0.631 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
hold |
| Recommendation Mean |
3.14286 |
| Region |
US |
| Regular Market Change |
-0.17 |
| Regular Market Change Percent |
-0.730555 |
| Regular Market Day High |
23.24 |
| Regular Market Day Low |
22.91 |
| Regular Market Day Range |
22.91 - 23.24 |
| Regular Market Open |
23.16 |
| Regular Market Previous Close |
23.27 |
| Regular Market Price |
23.1 |
| Regular Market Time |
1,787,947,203 |
| Regular Market Volume |
715,623 |
| Return On Assets |
0.0398 |
| Return On Equity |
0.08524 |
| Revenue Growth |
0.014 |
| Revenue Per Share |
34.6425 |
| Sand P52 Week Change |
0.20504117 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
532,219,370 |
| Shares Percent Shares Out |
0.0052 |
| Shares Short |
2,673,636 |
| Shares Short Previous Month Date |
1,784,073,600 |
| Shares Short Prior Month |
2,677,990 |
| Short Name |
Fresenius Medical Care AG |
| Short Ratio |
3.63 |
| Source Interval |
15 |
| Symbol |
FMS |
| Target High Price |
38.268833 |
| Target Low Price |
17.396292 |
| Target Mean Price |
25.760963 |
| Target Median Price |
24.823872 |
| Total Cash |
1,061,251,008 |
| Total Cash Per Share |
1.994 |
| Total Debt |
10,978,023,424 |
| Total Revenue |
19,427,147,776 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
1.49 |
| Trailing Annual Dividend Yield |
0.06403094 |
| Trailing Eps |
1.92 |
| Trailing P E |
12.03125 |
| Trailing Peg Ratio |
0.8091 |
| Triggerable |
1 |
| Two Hundred Day Average |
23.1421 |
| Two Hundred Day Average Change |
-0.042099 |
| Two Hundred Day Average Change Percent |
-0.0018191522 |
| Type Disp |
Equity |
| Volume |
715,623 |
| Website |
https://www.freseniusmedicalcare.com |
| Zip |
61,352 |